Abstract:Current methodologies for assessing vaccine effectiveness and longevity primarily center on measuring vaccine-induced neutralizing antibodies in serum or plasma. However, these methods overlook additional parameters such as the presence of memory B cells, even as antibody levels wane, and the pivotal role played by memory T cells in shaping antigen-specific memory B cell responses. Several studies have employed a combination of polyclonal activators, such as CpG and R848, along with various cytokines to provoke the recall of memory B cells from peripheral blood mononuclear cells (PBMCs) into antibody-secreting cells (ASCs). Other studies have examined the use of live attenuated viruses to stimulate antigen-specific memory T cells within PBMCs into effector T cells that produce Th1/Th2 cytokines. However, these studies have not fully elucidated the distinct effects of these polyclonal activators on individual subsets, nor have they evaluated whether the vaccine antigen alone is sufficient to trigger the recall of memory T cells. Thus, in this study, we directly compared the capacity of two B cell polyclonal activators to induce the transition of existing vaccine-specific memory cells present in peripheral blood samples into ASCs. Simultaneously, we also assessed the transition of existing memory T cells into effector subsets in response to vaccine antigens. Our findings demonstrate that both polyclonal activator combinations, CpG with IL-6 and IL-15, as well as R848 with IL-2, effectively induce the terminal differentiation of memory B cells into ASCs. Notably, CpG treatment preferentially expanded naïve and non-class-switched B cells, while R848 expanded class-switched memory cells, plasmablasts, and plasma cells. Consequently, R848 treatment led to a greater overall production of total and antigen-specific IgG immunoglobulins. Additionally, the exposure of isolated PBMCs to vaccine antigens alone proved sufficient for recalling the rare antigen-specific memory T cells into effector subsets, predominantly consisting of IFN-γ-producing CD4 T cells and TNF-β-producing CD8 T cells. This study not only establishes a rationale for the selection of methods to expand and detect antigen-specific lymphocyte subsets but also presents a means to quantify vaccine effectiveness by correlating serum antibody levels with preexisting memory cells within peripheral blood samples.

OCA-B/Pou2af1 is sufficient to promote CD4+ T cell memory and prospectively identifies memory precursors

Transcription Coactivator OCA-B Mediates Interactions Between Target Loci in T Cells and is Sufficient to Promote CD4 Memory in Vivo

Induction of Autonomous Memory Alveolar Macrophages Requires T Cell Help and is Critical to Trained Immunity

OCA-B promotes pathogenic maturation 1 of stem-like CD4+ T cells and autoimmune demyelination

Cognate CD4+ T Cells Enhance CTL Survival and Memory Programming Via IL-2, CD40L and Acquired Pmhc-I Signaling (46.16)

B cell intrinsic and extrinsic factors impacting memory recall responses to SRBC challenge

CD160 Signaling is Essential for CD8+ T Cell Memory Formation Via Upregulation of 4-1BB.

A comprehensive method for the phenotypical and functional characterization of recalled human memory B and T cells specific to vaccine antigens

Dysfunctional memory CD8+ T cells after priming in the absence of the cell cycle regulator E2F4

Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.

Novel Exosome-Targeted Cd4(+) T Cell Vaccine Counteracting Cd4(+)25(+) Regulatory T Cell-Mediated Immune Suppression and Stimulating Efficient Central Memory Cd8(+) Ctl Responses

Cd8(+) Cytotoxic T-Apc Stimulate Central Memoiry Cd8(+) T Cell Responses Via Acquired Peptide-Mhc Class I Complexes And Cd80 Costimulation, And Rl-2 Secretion

Sequential Administration of Cytokine Genes to Enhance Cellular Immune Responses and Cd4(+) T Memory Cells During Dna Vaccination

E2A-regulated epigenetic landscape promotes memory CD8 T cell differentiation

Enhanced memory development in mice by aptamer targeted mTORC1 inhibition in CD8+ T cells (110.3)

Antiviral memory B cells exhibit enhanced innate immune response facilitated by epigenetic memory

Inhibition of CDK4/6 Promotes CD8 T-cell Memory Formation

Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection

Abstract 1354: Anti-CTLA-4 generates memory T-cells with greater expansion and functionality than anti-PD-1

High recallability of memory B cells requires ZFP318-dependent transcriptional regulation of mitochondrial function

Expression of NAC1 Restrains the Memory Formation of CD8+ T Cells during Viral Infection